Amazon, Apple Earnings and Musk's DOGE Days
Bloomberg Businessweek
00:00
Eli Lilly's Market Dynamics and Economic Outlook
This chapter examines the fluctuations in Eli Lilly's stock, particularly following CVS's removal of its weight loss drug Zetbound from the preferred list. It analyzes pricing strategies in the competitive weight loss market, and addresses broader economic indicators such as inflation and tariffs that influence the pharmaceutical industry and investment landscape. The conversation highlights the complexities of supply chains and offers insights into the cautious long-term investment strategies amid shifting market conditions.
Transcript
Play full episode
